No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 2j31A, 1.0000, 0.00, 1.000, 240, 239, THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF(PRO)CASPASE-3
2, 5i9bA, 0.9990, 0.18, 0.992, 240, 239, CASPASE 3 V266A
3, 4qu8A, 0.9990, 0.18, 0.987, 240, 239, CASPASE-3 M61A V266H
4, 5ibpA, 0.9989, 0.19, 0.992, 240, 239, CASPASE 3 V266M
5, 2j32A, 0.9989, 0.18, 0.992, 240, 239, THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF(PRO)CASPASE-3
6, 2j30A, 0.9989, 0.18, 0.996, 245, 239, THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF (PRO)CASPASE-3
7, 5iarA, 0.9988, 0.20, 0.992, 240, 239, CASPASE 3 V266W
8, 5iaeC, 0.9988, 0.20, 0.992, 241, 239, CASPASE 3 V266F
9, 5iaeA, 0.9988, 0.19, 0.992, 241, 239, CASPASE 3 V266F
10, 4ehfA, 0.9987, 0.20, 0.987, 242, 239, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
11, 4ehdA, 0.9987, 0.20, 0.992, 239, 239, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
12, 3pcxA, 0.9987, 0.20, 0.987, 244, 239, CASPASE-3 E246A K242A DOUBLE MUTANT
13, 3itnA, 0.9987, 0.21, 0.992, 240, 239, CRYSTAL STRUCTURE OF PSEUDO-ACTIVATED PROCASPASE-3
14, 5ibcA, 0.9986, 0.21, 0.992, 241, 239, CASPASE 3 V266I
15, 4qtyA, 0.9986, 0.21, 0.992, 240, 239, CASPASE-3 E190A
16, 4pryA, 0.9986, 0.21, 0.996, 249, 239, CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
17, 5iagA, 0.9985, 0.22, 0.992, 239, 239, CASPASE 3 V266Q
18, 4jjeA, 0.9985, 0.22, 0.996, 240, 239, CASPASE-3 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
19, 5iasA, 0.9984, 0.23, 0.992, 240, 239, CASPASE 3 V266Y
20, 4qujA, 0.9984, 0.23, 0.987, 240, 239, CASPASE-3 T140GV266H
21, 4quiA, 0.9984, 0.23, 0.987, 248, 239, CASPASE-3 F128AV266H
22, 4qu0A, 0.9982, 0.24, 0.987, 240, 239, CASPASE-3 Y195AV266H
23, 4quaA, 0.9966, 0.44, 0.992, 240, 239, CASPASE-3 Y195F
24, 5iakA, 0.9964, 0.47, 0.992, 240, 239, CASPASE 3 V266S
25, 4qu5A, 0.9964, 0.45, 0.992, 240, 239, CASPASE-3 T140V
26, 5ianA, 0.9957, 0.47, 0.992, 240, 239, CASPASE 3 V266N
27, 5i9tA, 0.9949, 0.17, 0.992, 239, 238, CASPASE 3 V266C
28, 4qu9A, 0.9947, 0.18, 0.992, 240, 238, CASPASE-3 F128A
29, 4qubA, 0.9946, 0.20, 0.992, 240, 238, CASPASE-3 K137A
30, 4quiB, 0.9945, 0.21, 0.987, 248, 238, CASPASE-3 F128AV266H
31, 5i9tC, 0.9927, 0.42, 0.992, 239, 238, CASPASE 3 V266C
32, 3pd0A, 0.9906, 0.18, 0.987, 238, 237, CASPASE-3 E246A
33, 3pd1A, 0.9905, 0.19, 0.992, 238, 237, CASPASE-3 K242A
34, 4qtxA, 0.9898, 0.24, 0.992, 237, 237, CASPASE-3 Y195A
35, 4qudA, 0.9885, 0.57, 0.992, 238, 238, CASPASE-3 T140F
36, 4ehhA, 0.9820, 0.21, 0.991, 235, 235, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
37, 1nmqB, 0.9771, 0.25, 0.991, 238, 234, EXTENDEND TETHERING: IN SITU ASSEMBLY OF INHIBITORS
38, 1nmqA, 0.9771, 0.26, 0.991, 238, 234, EXTENDEND TETHERING: IN SITU ASSEMBLY OF INHIBITORS
39, 4ps0A, 0.9769, 0.27, 0.996, 244, 234, CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
40, 4qulC, 0.9764, 0.30, 0.991, 235, 234, CASPASE-3 F55W
41, 5iajA, 0.9753, 0.47, 0.991, 235, 234, CASPASE 3 V266L
42, 1nmsA, 0.9747, 0.39, 0.991, 240, 234, CASPASE-3 TETHERED TO IRREVERSIBLE INHIBITOR
43, 5iabA, 0.9746, 0.39, 0.991, 235, 234, CASPASE 3 V266D
44, 1nmsB, 0.9743, 0.41, 0.991, 240, 234, CASPASE-3 TETHERED TO IRREVERSIBLE INHIBITOR
45, 4ehnA, 0.9737, 0.20, 0.983, 233, 233, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
46, 2j33A, 0.9737, 0.20, 0.991, 234, 233, THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF (PRO)CASPASE-3
47, 4fdlB, 0.9732, 0.84, 0.564, 239, 236, CRYSTAL STRUCTURE OF CASPASE-7
48, 4ps0B, 0.9729, 0.26, 0.996, 237, 233, CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
49, 4quhC, 0.9727, 0.27, 0.991, 234, 233, CASPASE-3 T140G
50, 4ehkC, 0.9721, 0.30, 0.987, 233, 233, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
51, 4queA, 0.9718, 0.36, 0.983, 234, 233, CASPASE-3 Y195FV266H
52, 3dekB, 0.9718, 0.32, 0.991, 234, 233, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
53, 4quhA, 0.9713, 0.35, 0.991, 233, 233, CASPASE-3 T140G
54, 3h0eB, 0.9713, 0.35, 0.996, 238, 233, 34-DIHYDROPYRIMIDO(12-A)INDOL-10(2H)-ONES AS POTENT NON- PEPTIDIC INHIBITORS OF CASPASE-3
55, 5jftA, 0.9711, 0.71, 0.621, 238, 235, ZEBRA FISH CASPASE-3
56, 5iabC, 0.9711, 0.43, 0.991, 234, 233, CASPASE 3 V266D
57, 3dejB, 0.9711, 0.36, 0.991, 234, 233, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
58, 3dehB, 0.9711, 0.36, 0.991, 234, 233, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
59, 4qugA, 0.9690, 0.24, 0.991, 232, 232, CASPASE-3 M61A
60, 4queC, 0.9684, 0.28, 0.987, 232, 232, CASPASE-3 Y195FV266H
61, 3deiD, 0.9683, 0.48, 0.991, 233, 233, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
62, 5jftB, 0.9680, 0.64, 0.624, 235, 234, ZEBRA FISH CASPASE-3
63, 4ehaA, 0.9678, 0.31, 0.991, 232, 232, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
64, 1qx3A, 0.9678, 0.31, 0.991, 232, 232, CONFORMATIONAL RESTRICTIONS IN THE ACTIVE SITE OF UNLIGANDED HUMAN CASPASE-3
65, 4qugC, 0.9674, 0.34, 0.991, 232, 232, CASPASE-3 M61A
66, 3deiB, 0.9672, 0.34, 0.991, 232, 232, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
67, 4ehkA, 0.9669, 0.44, 0.987, 233, 232, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
68, 4ehaC, 0.9669, 0.36, 0.991, 232, 232, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
69, 3dekC, 0.9666, 0.55, 0.991, 234, 233, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
70, 3h0eA, 0.9664, 0.38, 0.996, 237, 232, 34-DIHYDROPYRIMIDO(12-A)INDOL-10(2H)-ONES AS POTENT NON- PEPTIDIC INHIBITORS OF CASPASE-3
71, 4ehlC, 0.9661, 0.48, 0.987, 232, 232, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
72, 1cp3A, 0.9661, 0.40, 0.991, 232, 232, CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE INHIBITOR ACE-DVAD-FMC
73, 3deiC, 0.9659, 0.57, 0.991, 233, 233, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
74, 1cp3B, 0.9657, 0.42, 0.991, 232, 232, CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE INHIBITOR ACE-DVAD-FMC
75, 3dekA, 0.9652, 0.44, 0.991, 232, 232, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
76, 4jr2B, 0.9647, 0.61, 0.571, 233, 233, HUMAN PROCASPASE-7/CASPASE-7 HETERODIMER BOUND TO AC-DEVD-CMK
77, 3dejA, 0.9645, 0.47, 0.991, 232, 232, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
78, 3dehA, 0.9645, 0.47, 0.991, 232, 232, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
79, 3dekD, 0.9642, 0.48, 0.991, 232, 232, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
80, 3r5kB, 0.9638, 0.62, 0.567, 237, 233, A DESIGNED REDOX-CONTROLLED CASPASE-7
81, 1i4oA, 0.9629, 1.13, 0.566, 235, 235, CRYSTAL STRUCTURE OF THE XIAP/CASPASE-7 COMPLEX
82, 3dehC, 0.9626, 0.54, 0.991, 232, 232, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
83, 4ehlA, 0.9624, 0.45, 0.987, 231, 231, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
84, 3r5kA, 0.9624, 0.66, 0.567, 234, 233, A DESIGNED REDOX-CONTROLLED CASPASE-7
85, 3dejC, 0.9621, 0.56, 0.991, 232, 232, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
86, 1kmcA, 0.9614, 0.73, 0.567, 234, 233, CRYSTAL STRUCTURE OF THE CASPASE-7 / XIAP-BIR2 COMPLEX
87, 3h1pB, 0.9607, 0.59, 0.565, 233, 232, MATURE CASPASE-7 I213A WITH DEVD-CHO INHIBITOR BOUND TO ACTIVE SITE
88, 3h1pA, 0.9605, 0.60, 0.565, 232, 232, MATURE CASPASE-7 I213A WITH DEVD-CHO INHIBITOR BOUND TO ACTIVE SITE
89, 3deiA, 0.9601, 0.48, 0.991, 231, 231, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
90, 4qulA, 0.9597, 0.30, 0.991, 230, 230, CASPASE-3 F55W
91, 1kmcB, 0.9597, 0.83, 0.567, 234, 233, CRYSTAL STRUCTURE OF THE CASPASE-7 / XIAP-BIR2 COMPLEX
92, 4fdlA, 0.9594, 0.63, 0.573, 232, 232, CRYSTAL STRUCTURE OF CASPASE-7
93, 5ibrA, 0.9590, 0.46, 0.991, 230, 230, CASPASE 3 V266K
94, 1i4oB, 0.9588, 0.76, 0.573, 232, 232, CRYSTAL STRUCTURE OF THE XIAP/CASPASE-7 COMPLEX
95, 4qudB, 0.9571, 0.51, 0.991, 230, 230, CASPASE-3 T140F
96, 1f1jB, 0.9570, 0.58, 0.571, 231, 231, CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP- CHO
97, 1m72B, 0.9564, 1.22, 0.404, 248, 235, CRYSTAL STRUCTURE OF CASPASE-1 FROM SPODOPTERA FRUGIPERDA
98, 4jj8A, 0.9563, 0.60, 0.576, 231, 231, CASPASE-3 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
99, 1m72A, 0.9563, 1.20, 0.404, 247, 235, CRYSTAL STRUCTURE OF CASPASE-1 FROM SPODOPTERA FRUGIPERDA
100, 1m72C, 0.9562, 1.22, 0.404, 252, 235, CRYSTAL STRUCTURE OF CASPASE-1 FROM SPODOPTERA FRUGIPERDA
101, 4jj8B, 0.9561, 0.61, 0.576, 231, 231, CASPASE-3 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
102, 4hvaB, 0.9553, 1.47, 0.435, 241, 237, MECHANISTIC AND STRUCTURAL UNDERSTANDING OF UNCOMPETITIVE INHIBITORS OF CASPASE-6
103, 5ibrC, 0.9546, 0.50, 0.991, 229, 229, CASPASE 3 V266K
104, 4hvaA, 0.9541, 1.54, 0.435, 238, 237, MECHANISTIC AND STRUCTURAL UNDERSTANDING OF UNCOMPETITIVE INHIBITORS OF CASPASE-6
105, 3s70C, 0.9535, 1.56, 0.435, 239, 237, CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 BOUND WITH AC-VEID-CHO SOLVED BY AS-SAD
106, 3od5A, 0.9534, 1.56, 0.435, 240, 237, CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 BOUND WITH AC-VEID-CHO
107, 3s70A, 0.9530, 1.57, 0.435, 241, 237, CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 BOUND WITH AC-VEID-CHO SOLVED BY AS-SAD
108, 3od5B, 0.9528, 1.57, 0.435, 240, 237, CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 BOUND WITH AC-VEID-CHO
109, 1f1jA, 0.9528, 0.58, 0.574, 230, 230, CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP- CHO
110, 3dehD, 0.9479, 0.46, 0.991, 228, 228, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
111, 3dejD, 0.9472, 0.49, 0.991, 228, 228, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
112, 4hqrB, 0.9465, 0.95, 0.570, 230, 230, CRYSTAL STRUCTURE OF MUTANT FORM OF CASPASE-7
113, 4jr0A, 0.9358, 0.70, 0.996, 226, 226, HUMAN PROCASPASE-3 BOUND TO AC-DEVD-CMK
114, 4jr0B, 0.9322, 0.85, 0.991, 226, 226, HUMAN PROCASPASE-3 BOUND TO AC-DEVD-CMK
115, 1k86A, 0.9287, 1.32, 0.565, 232, 230, CRYSTAL STRUCTURE OF CASPASE-7
116, 4jr2A, 0.9262, 0.65, 0.571, 224, 224, HUMAN PROCASPASE-7/CASPASE-7 HETERODIMER BOUND TO AC-DEVD-CMK
117, 4jr1B, 0.9229, 1.16, 0.571, 228, 226, HUMAN PROCASPASE-7 BOUND TO AC-DEVD-CMK
118, 4ps1A, 0.9200, 1.20, 0.399, 238, 228, CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
119, 4jj7A, 0.9195, 1.24, 0.390, 241, 228, CASPASE-3 SPECIFIC UNNATURAL AMINO ACID-BASED PEPTIDES
120, 2funB, 0.9191, 1.31, 0.397, 243, 229, ALTERNATIVE P35-CASPASE-8 COMPLEX
121, 4ps1B, 0.9189, 1.23, 0.399, 238, 228, CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
122, 1i4eB, 0.9189, 1.31, 0.397, 243, 229, CRYSTAL STRUCTURE OF THE CASPASE-8/P35 COMPLEX
123, 4m9rA, 0.9185, 1.36, 0.371, 256, 229, CRYSTAL STRUCTURE OF CED-3
124, 4przA, 0.9184, 1.26, 0.390, 240, 228, CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
125, 4ps1C, 0.9182, 1.27, 0.390, 237, 228, CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
126, 2funD, 0.9173, 1.22, 0.399, 241, 228, ALTERNATIVE P35-CASPASE-8 COMPLEX
127, 4ps1D, 0.9155, 1.20, 0.392, 236, 227, CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
128, 3v3kC, 0.9122, 1.26, 0.385, 237, 226, HUMAN CASPASE 9 IN COMPLEX WITH BACTERIAL EFFECTOR PROTEIN
129, 3v3kG, 0.9120, 1.27, 0.385, 235, 226, HUMAN CASPASE 9 IN COMPLEX WITH BACTERIAL EFFECTOR PROTEIN
130, 3v3kK, 0.9113, 1.27, 0.385, 237, 226, HUMAN CASPASE 9 IN COMPLEX WITH BACTERIAL EFFECTOR PROTEIN
131, 3v3kE, 0.9106, 1.47, 0.383, 243, 227, HUMAN CASPASE 9 IN COMPLEX WITH BACTERIAL EFFECTOR PROTEIN
132, 3v3kO, 0.9102, 1.31, 0.385, 237, 226, HUMAN CASPASE 9 IN COMPLEX WITH BACTERIAL EFFECTOR PROTEIN
133, 3v3kA, 0.9093, 1.29, 0.385, 245, 226, HUMAN CASPASE 9 IN COMPLEX WITH BACTERIAL EFFECTOR PROTEIN
134, 3v3kI, 0.9091, 1.30, 0.385, 244, 226, HUMAN CASPASE 9 IN COMPLEX WITH BACTERIAL EFFECTOR PROTEIN
135, 3v3kM, 0.9089, 1.51, 0.383, 245, 227, HUMAN CASPASE 9 IN COMPLEX WITH BACTERIAL EFFECTOR PROTEIN
136, 1k86B, 0.9051, 1.79, 0.566, 232, 226, CRYSTAL STRUCTURE OF CASPASE-7
137, 1jxqC, 0.8989, 1.65, 0.387, 242, 225, STRUCTURE OF CLEAVED CARD DOMAIN DELETED CASPASE-9
138, 1jxqA, 0.8987, 1.66, 0.387, 242, 225, STRUCTURE OF CLEAVED CARD DOMAIN DELETED CASPASE-9
139, 4n5dA, 0.8933, 2.09, 0.432, 257, 229, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6: CPD1
140, 4n7mA, 0.8906, 2.13, 0.432, 256, 229, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
141, 4nblA, 0.8905, 2.15, 0.432, 258, 229, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
142, 4nbkA, 0.8903, 2.16, 0.432, 256, 229, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
143, 4n7jA, 0.8896, 2.15, 0.432, 256, 229, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
144, 4nbnA, 0.8894, 2.16, 0.432, 257, 229, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
145, 4n6gA, 0.8893, 2.18, 0.432, 257, 229, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
146, 4n5dB, 0.8850, 2.06, 0.438, 243, 226, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6: CPD1
147, 4n7jB, 0.8847, 2.06, 0.438, 243, 226, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
148, 4n7mB, 0.8846, 2.06, 0.438, 243, 226, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
149, 4n6gB, 0.8845, 2.19, 0.432, 243, 227, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
150, 4nblB, 0.8842, 2.24, 0.432, 242, 227, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
151, 4nbnB, 0.8838, 2.24, 0.432, 242, 227, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
152, 4nbkB, 0.8837, 2.25, 0.432, 243, 227, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
153, 4hqrA, 0.8822, 1.24, 0.560, 217, 216, CRYSTAL STRUCTURE OF MUTANT FORM OF CASPASE-7
154, 4ejfC, 0.8809, 2.23, 0.436, 243, 227, ALLOSTERIC PEPTIDES THAT BIND TO A CASPASE ZYMOGEN AND MEDIATE CASPASE TETRAMERIZATION
155, 4ejfB, 0.8802, 2.16, 0.434, 243, 226, ALLOSTERIC PEPTIDES THAT BIND TO A CASPASE ZYMOGEN AND MEDIATE CASPASE TETRAMERIZATION
156, 4ejfD, 0.8799, 2.31, 0.432, 243, 227, ALLOSTERIC PEPTIDES THAT BIND TO A CASPASE ZYMOGEN AND MEDIATE CASPASE TETRAMERIZATION
157, 3v6lB, 0.8796, 2.26, 0.438, 241, 226, CRYSTAL STRUCTURE OF CASPASE-6 INACTIVATION MUTATION
158, 4ejfA, 0.8785, 2.33, 0.436, 243, 227, ALLOSTERIC PEPTIDES THAT BIND TO A CASPASE ZYMOGEN AND MEDIATE CASPASE TETRAMERIZATION
159, 4iyrA, 0.8776, 2.34, 0.436, 248, 227, CRYSTAL STRUCTURE OF FULL-LENGTH CASPASE-6 ZYMOGEN
160, 1k88A, 0.8754, 1.90, 0.547, 227, 223, CRYSTAL STRUCTURE OF PROCASPASE-7
161, 4jr1A, 0.8753, 0.93, 0.565, 223, 214, HUMAN PROCASPASE-7 BOUND TO AC-DEVD-CMK
162, 3v6lA, 0.8751, 2.29, 0.444, 239, 225, CRYSTAL STRUCTURE OF CASPASE-6 INACTIVATION MUTATION
163, 3nr2A, 0.8602, 1.98, 0.454, 233, 218, CRYSTAL STRUCTURE OF CASPASE-6 ZYMOGEN
164, 3h11B, 0.8596, 1.40, 0.402, 229, 214, ZYMOGEN CASPASE-8:C-FLIPL PROTEASE DOMAIN COMPLEX
165, 5v6uB, 0.8582, 1.03, 0.555, 213, 209, CRYSTAL STRUCTURE OF HUMAN CASPASE-7 SOAKED WITH ALLOSTERIC INHIBITOR 2-[(2-ACETYLPHENYL)SULFANYL]BENZOIC ACID
166, 1gqfA, 0.8580, 2.35, 0.525, 265, 221, CRYSTAL STRUCTURE OF HUMAN PROCASPASE-7
167, 1gqfB, 0.8549, 2.43, 0.520, 264, 221, CRYSTAL STRUCTURE OF HUMAN PROCASPASE-7
168, 3nr2B, 0.8537, 2.11, 0.452, 230, 217, CRYSTAL STRUCTURE OF CASPASE-6 ZYMOGEN
169, 2ar9A, 0.8505, 1.73, 0.407, 230, 214, CRYSTAL STRUCTURE OF A DIMERIC CASPASE-9
170, 1k88B, 0.8498, 2.16, 0.542, 234, 216, CRYSTAL STRUCTURE OF PROCASPASE-7
171, 4hq0B, 0.8495, 1.32, 0.555, 217, 209, CRYSTAL STRUCTURE OF MUTANT FORM OF CASPASE-7
172, 4hq0A, 0.8493, 1.42, 0.562, 210, 210, CRYSTAL STRUCTURE OF MUTANT FORM OF CASPASE-7
173, 5v6zB, 0.8462, 0.96, 0.549, 210, 206, CRYSTAL STRUCTURE OF HUMAN CASPASE-7 SOAKED WITH ALLOSTERIC INHIBITOR 2-{[2-(4-CHLOROPHENYL)-2-OXOETHYL]SULFANYL}BENZOIC ACID
174, 5v6uA, 0.8458, 0.70, 0.561, 205, 205, CRYSTAL STRUCTURE OF HUMAN CASPASE-7 SOAKED WITH ALLOSTERIC INHIBITOR 2-[(2-ACETYLPHENYL)SULFANYL]BENZOIC ACID
175, 2nn3D, 0.8453, 2.58, 0.381, 260, 223, STRUCTURE OF PRO-SF-CASPASE-1
176, 2ar9C, 0.8448, 1.82, 0.407, 230, 214, CRYSTAL STRUCTURE OF A DIMERIC CASPASE-9
177, 1jxqB, 0.8318, 1.87, 0.373, 226, 212, STRUCTURE OF CLEAVED CARD DOMAIN DELETED CASPASE-9
178, 1jxqD, 0.8316, 1.87, 0.373, 226, 212, STRUCTURE OF CLEAVED CARD DOMAIN DELETED CASPASE-9
179, 2nn3C, 0.8307, 2.62, 0.374, 235, 219, STRUCTURE OF PRO-SF-CASPASE-1
180, 5v6zA, 0.8298, 0.69, 0.552, 201, 201, CRYSTAL STRUCTURE OF HUMAN CASPASE-7 SOAKED WITH ALLOSTERIC INHIBITOR 2-{[2-(4-CHLOROPHENYL)-2-OXOETHYL]SULFANYL}BENZOIC ACID
181, 3s8eD, 0.8261, 2.12, 0.438, 221, 210, PHOSPHORYLATION REGULATES ASSEMBLY OF THE CASPASE-6 SUBSTRATE-BINDING GROOVE
182, 3s8eC, 0.8243, 2.12, 0.445, 219, 209, PHOSPHORYLATION REGULATES ASSEMBLY OF THE CASPASE-6 SUBSTRATE-BINDING GROOVE
183, 3s8eF, 0.8230, 2.19, 0.443, 222, 210, PHOSPHORYLATION REGULATES ASSEMBLY OF THE CASPASE-6 SUBSTRATE-BINDING GROOVE
184, 3s8eG, 0.8225, 2.24, 0.440, 216, 209, PHOSPHORYLATION REGULATES ASSEMBLY OF THE CASPASE-6 SUBSTRATE-BINDING GROOVE
185, 3s8eA, 0.8223, 2.03, 0.442, 219, 208, PHOSPHORYLATION REGULATES ASSEMBLY OF THE CASPASE-6 SUBSTRATE-BINDING GROOVE
186, 2ar9B, 0.8207, 2.03, 0.393, 232, 211, CRYSTAL STRUCTURE OF A DIMERIC CASPASE-9
187, 3s8eE, 0.8205, 2.04, 0.442, 219, 208, PHOSPHORYLATION REGULATES ASSEMBLY OF THE CASPASE-6 SUBSTRATE-BINDING GROOVE
188, 1shjB, 0.8203, 1.77, 0.546, 209, 205, CASPASE-7 IN COMPLEX WITH DICA ALLOSTERIC INHIBITOR
189, 3s8eH, 0.8193, 2.13, 0.447, 217, 208, PHOSPHORYLATION REGULATES ASSEMBLY OF THE CASPASE-6 SUBSTRATE-BINDING GROOVE
190, 3s8eB, 0.8181, 1.95, 0.447, 214, 206, PHOSPHORYLATION REGULATES ASSEMBLY OF THE CASPASE-6 SUBSTRATE-BINDING GROOVE
191, 2ar9D, 0.8174, 2.03, 0.390, 231, 210, CRYSTAL STRUCTURE OF A DIMERIC CASPASE-9
192, 3e4cA, 0.8149, 2.37, 0.274, 271, 215, PROCASPASE-1 ZYMOGEN DOMAIN CRYSTAL STRUCUTRE
193, 1shjA, 0.8148, 1.63, 0.550, 208, 202, CASPASE-7 IN COMPLEX WITH DICA ALLOSTERIC INHIBITOR
194, 1nw9B, 0.8147, 2.07, 0.362, 238, 210, STRUCTURE OF CASPASE-9 IN AN INHIBITORY COMPLEX WITH XIAP- BIR3
195, 1shlB, 0.8099, 1.31, 0.553, 200, 199, CASPASE-7 IN COMPLEX WITH FICA ALLOSTERIC INHIBITOR
196, 3v6mA, 0.8089, 1.85, 0.446, 205, 202, INHIBITION OF CASPASE-6 ACTIVITY BY SINGLE MUTATION OUTSIDE THE ACTIVE SITE
197, 3v6mJ, 0.8079, 1.81, 0.441, 206, 202, INHIBITION OF CASPASE-6 ACTIVITY BY SINGLE MUTATION OUTSIDE THE ACTIVE SITE
198, 3e4cB, 0.8063, 2.22, 0.280, 257, 211, PROCASPASE-1 ZYMOGEN DOMAIN CRYSTAL STRUCUTRE
199, 3v6mC, 0.8054, 1.79, 0.443, 205, 201, INHIBITION OF CASPASE-6 ACTIVITY BY SINGLE MUTATION OUTSIDE THE ACTIVE SITE
200, 4feaB, 0.8053, 0.81, 0.541, 196, 196, CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ALLOSTERIC INHIBITOR
201, 1shlA, 0.8051, 0.89, 0.541, 198, 196, CASPASE-7 IN COMPLEX WITH FICA ALLOSTERIC INHIBITOR
202, 3v6mG, 0.8028, 1.76, 0.445, 204, 200, INHIBITION OF CASPASE-6 ACTIVITY BY SINGLE MUTATION OUTSIDE THE ACTIVE SITE
203, 3v6mI, 0.8025, 1.77, 0.445, 204, 200, INHIBITION OF CASPASE-6 ACTIVITY BY SINGLE MUTATION OUTSIDE THE ACTIVE SITE
204, 3v6mD, 0.8025, 1.78, 0.445, 204, 200, INHIBITION OF CASPASE-6 ACTIVITY BY SINGLE MUTATION OUTSIDE THE ACTIVE SITE
205, 3v6mB, 0.8020, 1.78, 0.445, 204, 200, INHIBITION OF CASPASE-6 ACTIVITY BY SINGLE MUTATION OUTSIDE THE ACTIVE SITE
206, 3v6mF, 0.8017, 1.60, 0.447, 203, 199, INHIBITION OF CASPASE-6 ACTIVITY BY SINGLE MUTATION OUTSIDE THE ACTIVE SITE
207, 2fp3A, 0.7921, 2.56, 0.227, 254, 211, CRYSTAL STRUCTURE OF THE DROSOPHILA INITIATOR CASPASE DRONC
208, 2wdpA, 0.7841, 2.84, 0.458, 224, 212, CRYSTAL STRUCTURE OF LIGAND FREE HUMAN CASPASE-6
209, 2wdpB, 0.7815, 2.90, 0.446, 227, 213, CRYSTAL STRUCTURE OF LIGAND FREE HUMAN CASPASE-6
210, 2wdpD, 0.7805, 3.15, 0.445, 230, 218, CRYSTAL STRUCTURE OF LIGAND FREE HUMAN CASPASE-6
211, 4m9rB, 0.7804, 1.51, 0.367, 223, 196, CRYSTAL STRUCTURE OF CED-3
212, 4fxoB, 0.7794, 3.01, 0.434, 227, 212, ZINC-MEDIATED ALLOSTERIC INHIBITON OF CASPASE-6
213, 2wdpC, 0.7730, 3.15, 0.442, 227, 215, CRYSTAL STRUCTURE OF LIGAND FREE HUMAN CASPASE-6
214, 4jqyB, 0.7722, 1.99, 0.934, 205, 198, HUMAN PROCASPASE-3 CRYSTAL FORM 1
215, 3nkfD, 0.7707, 3.02, 0.462, 220, 210, CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6 WITH INTERSUBUNIT LINKER ATTACHED
216, 4jqzA, 0.7687, 1.74, 0.974, 197, 194, HUMAN PROCASPASE-3 CRYSTAL FORM 2
217, 3nkfC, 0.7646, 2.80, 0.449, 222, 207, CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6 WITH INTERSUBUNIT LINKER ATTACHED
218, 3h13A, 0.7639, 2.14, 0.290, 208, 200, C-FLIPL PROTEASE-LIKE DOMAIN
219, 4fxoC, 0.7602, 2.97, 0.447, 220, 206, ZINC-MEDIATED ALLOSTERIC INHIBITON OF CASPASE-6
220, 3h11A, 0.7601, 2.36, 0.289, 212, 201, ZYMOGEN CASPASE-8:C-FLIPL PROTEASE DOMAIN COMPLEX
221, 3nkfA, 0.7590, 3.12, 0.459, 219, 209, CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6 WITH INTERSUBUNIT LINKER ATTACHED
222, 4jqyA, 0.7582, 1.74, 0.969, 194, 191, HUMAN PROCASPASE-3 CRYSTAL FORM 1
223, 4fxoD, 0.7574, 2.88, 0.446, 220, 204, ZINC-MEDIATED ALLOSTERIC INHIBITON OF CASPASE-6
224, 3v4lA, 0.7565, 2.19, 0.170, 386, 200, MOUSE MALT1(CASPASE-IG3 DOMAINS) IN COMPLEX WITH A IRREVERSIBLE PEPTIDIC INHIBITOR
225, 3k7eA, 0.7551, 2.89, 0.463, 214, 205, CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6
226, 3v4oA, 0.7547, 2.23, 0.185, 234, 200, HUMAN MALT1 (CASPASE DOMAIN) IN COMPLEX WITH AN IRREVERSIBLE PEPTIDIC INHIBITOR
227, 3nkfB, 0.7533, 2.96, 0.456, 213, 206, CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6 WITH INTERSUBUNIT LINKER ATTACHED
228, 3k7eC, 0.7528, 2.90, 0.456, 212, 204, CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6
229, 3uoaB, 0.7518, 2.14, 0.182, 364, 198, CRYSTAL STRUCTURE OF THE MALT1 PARACASPASE (P21 FORM)
230, 3uo8C, 0.7518, 2.14, 0.182, 363, 198, CRYSTAL STRUCTURE OF THE MALT1 PARACASPASE (P1 FORM)
231, 4i1pC, 0.7515, 2.15, 0.187, 380, 198, HUMAN MALT1 (CASPASE-IG3) IN COMPLEX WITH ACTIVITY BASED-PROBE
232, 3uoaC, 0.7513, 2.15, 0.182, 363, 198, CRYSTAL STRUCTURE OF THE MALT1 PARACASPASE (P21 FORM)
233, 4iyrB, 0.7510, 1.81, 0.463, 191, 188, CRYSTAL STRUCTURE OF FULL-LENGTH CASPASE-6 ZYMOGEN
234, 3uo8B, 0.7510, 2.16, 0.182, 364, 198, CRYSTAL STRUCTURE OF THE MALT1 PARACASPASE (P1 FORM)
235, 4i1pA, 0.7493, 2.18, 0.182, 379, 198, HUMAN MALT1 (CASPASE-IG3) IN COMPLEX WITH ACTIVITY BASED-PROBE
236, 4fxoA, 0.7479, 2.89, 0.448, 219, 201, ZINC-MEDIATED ALLOSTERIC INHIBITON OF CASPASE-6
237, 3k7eD, 0.7473, 2.98, 0.463, 213, 203, CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6
238, 4jqzB, 0.7278, 1.17, 0.983, 182, 178, HUMAN PROCASPASE-3 CRYSTAL FORM 2
239, 3k7eB, 0.7193, 2.86, 0.448, 200, 194, CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6
240, 3bijA, 0.7172, 2.69, 0.137, 258, 197, CRYSTAL STRUCTURE OF PROTEIN GSU0716 FROM GEOBACTER SULFURREDUCENS. NORTHEAST STRUCTURAL GENOMICS TARGET GSR13
241, 3sirA, 0.7160, 3.00, 0.399, 214, 193, CRYSTAL STRUCTURE OF DRICE
242, 3bijB, 0.7136, 2.65, 0.133, 255, 196, CRYSTAL STRUCTURE OF PROTEIN GSU0716 FROM GEOBACTER SULFURREDUCENS. NORTHEAST STRUCTURAL GENOMICS TARGET GSR13
243, 3bijC, 0.7131, 2.63, 0.133, 257, 196, CRYSTAL STRUCTURE OF PROTEIN GSU0716 FROM GEOBACTER SULFURREDUCENS. NORTHEAST STRUCTURAL GENOMICS TARGET GSR13
244, 3v55A, 0.7120, 2.48, 0.181, 368, 193, HUMAN MALT1 (334-719) IN ITS LIGAND FREE FORM
245, 4i1rA, 0.7037, 2.40, 0.180, 353, 189, HUMAN MALT1 (CASPASE-IG3) IN COMPLEX WITH THIORIDAZINE
246, 5nijB, 0.6977, 3.08, 0.091, 426, 198, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA LEGUMAIN ISOFORM GAMMA IN TWO-CHAIN ACTIVATION STATE
247, 5nijA, 0.6931, 3.07, 0.092, 427, 196, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA LEGUMAIN ISOFORM GAMMA IN TWO-CHAIN ACTIVATION STATE
248, 4nomA, 0.6930, 2.78, 0.124, 407, 193, CRYSTAL STRUCTURE OF ASPARAGINYL ENDOPEPTIDASE (AEP)/LEGUMAIN ACTIVATED AT PH 4.5
249, 5nijC, 0.6927, 3.06, 0.092, 427, 196, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA LEGUMAIN ISOFORM GAMMA IN TWO-CHAIN ACTIVATION STATE
250, 5nijD, 0.6914, 3.08, 0.092, 426, 196, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA LEGUMAIN ISOFORM GAMMA IN TWO-CHAIN ACTIVATION STATE
251, 4feaA, 0.6906, 1.05, 0.535, 170, 170, CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ALLOSTERIC INHIBITOR
252, 5h0iB, 0.6898, 2.76, 0.109, 400, 192, NAME TO BE RELEASED WHEN PUBLISHED
253, 5zbiB, 0.6885, 2.77, 0.099, 415, 192, CRYSTAL STRUCTURE OF ASPARAGINYL ENDOPEPTIDASES FROM VIOLA CANADENSIS 
254, 4f6oA, 0.6879, 2.81, 0.156, 268, 192, CRYSTAL STRUCTURE OF THE YEAST METACASPASE YCA1
255, 5zbiA, 0.6875, 2.77, 0.099, 420, 192, CRYSTAL STRUCTURE OF ASPARAGINYL ENDOPEPTIDASES FROM VIOLA CANADENSIS 
256, 6aztA, 0.6871, 2.70, 0.084, 273, 190, ASPARAGINYL ENDOPEPTIDASE 1 BOUND TO AAN PEPTIDE A TETRAHEDRAL INTERMEDIATE
257, 5h0iA, 0.6861, 2.76, 0.110, 400, 191, NAME TO BE RELEASED WHEN PUBLISHED
258, 4f6pA, 0.6853, 2.70, 0.141, 261, 191, CRYSTAL STRUCTURE OF THE YEAST METACASPASE YCA1 C276A MUTANT
259, 4aw9A, 0.6848, 2.82, 0.126, 263, 191, CRYSTAL STRUCTURE OF ACTIVE LEGUMAIN IN COMPLEX WITH YVAD-CMK
260, 4awaA, 0.6847, 2.83, 0.126, 263, 191, CRYSTAL STRUCTURE OF ACTIVE LEGUMAIN IN COMPLEX WITH YVAD-CMK AT PH 5.0
261, 4awbA, 0.6842, 2.84, 0.126, 261, 191, CRYSTAL STRUCTURE OF ACTIVE LEGUMAIN IN COMPLEX WITH AAN-CMK
262, 4awbB, 0.6841, 2.82, 0.126, 262, 191, CRYSTAL STRUCTURE OF ACTIVE LEGUMAIN IN COMPLEX WITH AAN-CMK
263, 4n6oA, 0.6830, 2.81, 0.126, 262, 190, CRYSTAL STRUCTURE OF REDUCED LEGUMAIN IN COMPLEX WITH CYSTATIN E/M
264, 4d3zA, 0.6814, 2.82, 0.132, 389, 190, THE STRUCTURE OF INACTIVE PROLEGUMAIN FROM CHINESE HAMSTER TRIGONAL SPACE GROUP.
265, 5luaB, 0.6810, 2.84, 0.126, 261, 190, CRYSTAL STRUCTURE OF HUMAN LEGUMAIN (AEP) IN COMPLEX WITH COMPOUND 11B
266, 4nokA, 0.6809, 2.76, 0.143, 404, 189, CRYSTAL STRUCTURE OF PROENZYME ASPARAGINYL ENDOPEPTIDASE (AEP) /LEGUMAIN AT PH 7.5
267, 5lubB, 0.6808, 2.84, 0.126, 261, 190, CRYSTAL STRUCTURE OF HUMAN LEGUMAIN (AEP) IN COMPLEX WITH COMPOUND 11
268, 4nolB, 0.6808, 2.76, 0.143, 385, 189, CRYSTAL STRUCTURE OF PROENZYME ASPARAGINYL ENDOPEPTIDASE (AEP) /LEGUMAIN MUTANT D233A AT PH 7.5
269, 4nojA, 0.6806, 2.77, 0.138, 260, 189, CRYSTAL STRUCTURE OF THE MATURE FORM OF ASPARAGINYL ENDOPEPTIDASE (AEP)/LEGUMAIN ACTIVATED AT PH 3.5
270, 5lubA, 0.6805, 2.85, 0.126, 261, 190, CRYSTAL STRUCTURE OF HUMAN LEGUMAIN (AEP) IN COMPLEX WITH COMPOUND 11
271, 4nolA, 0.6805, 2.75, 0.143, 385, 189, CRYSTAL STRUCTURE OF PROENZYME ASPARAGINYL ENDOPEPTIDASE (AEP) /LEGUMAIN MUTANT D233A AT PH 7.5
272, 4n6nA, 0.6803, 2.86, 0.126, 261, 190, CRYSTAL STRUCTURE OF OXIDIZED LEGUMAIN IN COMPLEX WITH CYSTATIN E/M
273, 5luaA, 0.6802, 2.86, 0.116, 261, 190, CRYSTAL STRUCTURE OF HUMAN LEGUMAIN (AEP) IN COMPLEX WITH COMPOUND 11B
274, 5lu9A, 0.6800, 2.85, 0.126, 262, 190, CRYSTAL STRUCTURE OF YVAD-CMK BOUND HUMAN LEGUMAIN (AEP) IN COMPLEX WITH COMPOUND 11
275, 5lu8A, 0.6800, 2.85, 0.126, 262, 190, CRYSTAL STRUCTURE OF YVAD-CMK BOUND HUMAN LEGUMAIN (AEP) IN COMPLEX WITH COMPOUND 11B
276, 4fguA, 0.6785, 2.81, 0.127, 407, 189, CRYSTAL STRUCTURE OF PROLEGUMAIN
277, 4d3yA, 0.6783, 2.82, 0.127, 384, 189, THE STRUCTURE OF INACTIVE PROLEGUMAIN FROM CHINESE HAMSTER.
278, 4fguB, 0.6772, 2.82, 0.127, 404, 189, CRYSTAL STRUCTURE OF PROLEGUMAIN
279, 4d3xA, 0.6758, 2.85, 0.127, 259, 189, THE STRUCTURE OF MATURE LEGUMAIN FROM CHINESE HAMSTER.
280, 3sirB, 0.6724, 1.94, 0.429, 172, 170, CRYSTAL STRUCTURE OF DRICE
281, 4afvA, 0.6699, 3.38, 0.143, 317, 196, THE STRUCTURE OF METACASPASE 2 FROM T. BRUCEI DETERMINED IN THE PRESENCE OF CALCIUM CHLORIDE
282, 4afrA, 0.6675, 3.39, 0.144, 330, 195, THE STRUCTURE OF METACASPASE 2  (C213A MUTANT)  FROM T. BRUCEI
283, 4af8A, 0.6662, 3.40, 0.144, 332, 195, THE STRUCTURAL BASIS FOR METACASPASE SUBSTRATE SPECIFICITY AND ACTIVATION
284, 4afpA, 0.6635, 3.31, 0.145, 325, 193, THE STRUCTURE OF METACASPASE 2 FROM T. BRUCEI DETERMINED IN THE PRESENCE OF SAMARIUM
285, 3sirD, 0.6556, 1.18, 0.420, 169, 162, CRYSTAL STRUCTURE OF DRICE
286, 3sirC, 0.6519, 1.32, 0.414, 162, 162, CRYSTAL STRUCTURE OF DRICE
287, 1cvrA, 0.6194, 3.62, 0.058, 432, 189, CRYSTAL STRUCTURE OF THE ARG SPECIFIC CYSTEINE PROTEINASE GINGIPAIN R (RGPB)
288, 4iefH, 0.6140, 3.91, 0.062, 423, 192, COMPLEX OF PORPHYROMONAS GINGIVALIS RGPB PRO- AND MATURE DOMAINS
289, 4iefB, 0.6138, 3.91, 0.062, 422, 192, COMPLEX OF PORPHYROMONAS GINGIVALIS RGPB PRO- AND MATURE DOMAINS
290, 4iefF, 0.6136, 3.87, 0.058, 423, 191, COMPLEX OF PORPHYROMONAS GINGIVALIS RGPB PRO- AND MATURE DOMAINS
291, 4iefD, 0.6136, 3.87, 0.058, 423, 191, COMPLEX OF PORPHYROMONAS GINGIVALIS RGPB PRO- AND MATURE DOMAINS
292, 2k7zA, 0.6108, 3.78, 0.366, 229, 186, SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF PROCASPASE-8
293, 6bh9B, 0.6102, 0.18, 0.986, 146, 146, CASPASE-3 MUTANT - T152A
294, 6bh9A, 0.6102, 0.18, 0.986, 146, 146, CASPASE-3 MUTANT - T152A
295, 6bfjA, 0.6101, 0.20, 0.993, 146, 146, CASPASE-3 MUTANT - T245DS249D
296, 6bgqA, 0.6100, 0.21, 0.986, 146, 146, CASPASE-3 MUTANT - S150D
297, 6bgkA, 0.6100, 0.21, 0.986, 146, 146, CASPASE-3 MUTANT- D9AD28AT152D
298, 6bgsA, 0.6099, 0.23, 0.986, 146, 146, CASPASE-3 MUTANT - S150Y
299, 6bhaA, 0.6098, 0.24, 0.986, 146, 146, CASPASE-3 MUTANT - T152V
300, 2dkoA, 0.6098, 0.23, 0.993, 146, 146, EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH RESOLUTION X-RAY STRUCTURE ANALYSIS
301, 6bg1A, 0.6097, 0.25, 0.986, 146, 146, CASPASE-3 MUTANT - D9AD28AS150E
302, 2xypA, 0.6097, 0.25, 0.993, 146, 146, CASPASE-3:CAS26049945
303, 2cnlA, 0.6096, 0.26, 0.993, 147, 146, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS.
304, 2cnnA, 0.6095, 0.27, 0.993, 146, 146, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS.
305, 2cjyA, 0.6095, 0.27, 0.993, 146, 146, EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH RESOLUTION X-RAY STRUCTURE ANALYSIS
306, 2cnoA, 0.6094, 0.28, 0.993, 146, 146, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS.
307, 2c2oA, 0.6094, 0.28, 0.993, 146, 146, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS.
308, 2c2mA, 0.6094, 0.28, 0.993, 146, 146, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS.
309, 2cnkA, 0.6093, 0.28, 0.993, 146, 146, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS.
310, 2cjxA, 0.6093, 0.29, 0.993, 146, 146, EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH RESOLUTION X-RAY STRUCTURE ANALYSIS
311, 1nmeA, 0.6092, 0.30, 0.993, 146, 146, STRUCTURE OF CASP-3 WITH TETHERED SALICYLATE
312, 2cdrA, 0.6091, 0.31, 0.993, 147, 146, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS.
313, 2xyhA, 0.6090, 0.32, 0.993, 146, 146, CASPASE-3:CAS60254719
314, 2c2kA, 0.6090, 0.32, 0.993, 146, 146, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS.
315, 2c1eA, 0.6089, 0.33, 0.993, 146, 146, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS.
316, 2xygA, 0.6083, 0.37, 0.993, 146, 146, CASPASE-3:CAS329306
317, 2h5iA, 0.6081, 0.39, 0.993, 146, 146, CRYSTAL STRUCTURE OF CASPASE-3 WITH INHIBITOR AC-DEVD-CHO
318, 6bfoA, 0.6060, 0.19, 0.993, 145, 145, CASPASE-3 MUTANT- T245D
319, 6bgkB, 0.6058, 0.21, 0.986, 145, 145, CASPASE-3 MUTANT- D9AD28AT152D
320, 6bgqC, 0.6057, 0.22, 0.986, 145, 145, CASPASE-3 MUTANT - S150D
321, 6bgrA, 0.6053, 0.27, 0.986, 145, 145, CASPASE-3 MUTANT - S150E
322, 1gfwA, 0.6033, 0.43, 0.993, 145, 145, THE 2.8 ANGSTROM CRYSTAL STRUCTURE OF CASPASE-3 (APOPAIN OR CPP32)IN COMPLEX WITH AN ISATIN SULFONAMIDE INHIBITOR.
323, 6bfkA, 0.5974, 0.22, 0.993, 143, 143, CASPASE-3 MUTANT- T245A
324, 6bfkB, 0.5971, 0.26, 0.993, 143, 143, CASPASE-3 MUTANT- T245A
325, 1i3oA, 0.5937, 0.59, 0.986, 143, 143, CRYSTAL STRUCTURE OF THE COMPLEX OF XIAP-BIR2 AND CASPASE 3
326, 1i3oC, 0.5933, 0.60, 0.986, 144, 143, CRYSTAL STRUCTURE OF THE COMPLEX OF XIAP-BIR2 AND CASPASE 3
327, 6bflA, 0.5893, 0.18, 0.993, 141, 141, CASPASE-3 MUTANT- D9AD28AT245D
328, 6bg4B, 0.5890, 0.22, 0.986, 141, 141, CASPASE-3 MUTANT- T152D
329, 6bdvA, 0.5890, 0.22, 0.986, 141, 141, CRYSTAL STRUCTURE OF CASPASE 3 S150A
330, 6bg0A, 0.5889, 0.24, 0.986, 141, 141, CASPASE-3 MUTANT - D9AD28AS150D
331, 3edqC, 0.5887, 0.26, 0.993, 141, 141, CRYSTAL STRUCTURE OF CASPASE-3 WITH INHIBITOR AC-LDESD-CHO
332, 6bg4A, 0.5884, 0.29, 0.986, 141, 141, CASPASE-3 MUTANT- T152D
333, 4dcpD, 0.5884, 0.30, 0.986, 141, 141, CRYSTAL STRUCTURE OF CASPASE 3 L168F MUTANT
334, 3gjrC, 0.5884, 0.29, 0.993, 141, 141, CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES
335, 4dcoD, 0.5883, 0.30, 0.986, 141, 141, CRYSTAL STRUCTURE OF CASPASE 3 L168Y MUTANT
336, 4dcjD, 0.5883, 0.30, 0.986, 141, 141, CRYSTAL STRUCTURE OF CASPASE 3 L168D MUTANT
337, 3gjrA, 0.5882, 0.31, 0.993, 141, 141, CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES
338, 6bg0B, 0.5879, 0.34, 0.986, 141, 141, CASPASE-3 MUTANT - D9AD28AS150D
339, 3gjqA, 0.5878, 0.34, 0.993, 141, 141, CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES
340, 2h65C, 0.5874, 0.38, 0.993, 141, 141, CRYSTAL STRUSTURE OF CASPASE-3 WITH INHIBITOR AC-VDVAD-CHO
341, 2h5jA, 0.5874, 0.38, 0.993, 141, 141, CRYSTAL STRUSTURE OF CASPASE-3 WITH INHIBITOR AC-DMQD-CHO
342, 3gjtA, 0.5873, 0.39, 0.993, 141, 141, CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES
343, 3gjsA, 0.5870, 0.41, 0.993, 141, 141, CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES
344, 4dcoA, 0.5860, 0.49, 0.986, 141, 141, CRYSTAL STRUCTURE OF CASPASE 3 L168Y MUTANT
345, 4dcpA, 0.5858, 0.50, 0.986, 141, 141, CRYSTAL STRUCTURE OF CASPASE 3 L168F MUTANT
346, 3ibfC, 0.5855, 0.90, 0.500, 145, 142, CRYSTAL STRUCTURE OF UNLIGANDED CASPASE-7
347, 4jb8A, 0.5852, 0.89, 0.500, 143, 142, CASPASE-7 IN COMPLEX WITH DARPIN C7_16
348, 3edrC, 0.5851, 0.93, 0.500, 145, 142, THE CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-LDESD-CHO
349, 4dcjA, 0.5849, 0.56, 0.986, 141, 141, CRYSTAL STRUCTURE OF CASPASE 3 L168D MUTANT
350, 2xzdC, 0.5849, 0.91, 0.986, 141, 141, CASPASE-3 IN COMPLEX WITH AN INHIBITORY DARPIN-3.4
351, 3kjfA, 0.5844, 0.28, 0.993, 140, 140, CASPASE 3 BOUND TO A COVALENT INHIBITOR
352, 1rhkA, 0.5844, 0.28, 0.993, 140, 140, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PHENYL-PROPYL- KETONE INHIBITOR
353, 1rhjA, 0.5844, 0.27, 0.993, 140, 140, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PRYAZINONE INHIBITOR
354, 1re1A, 0.5844, 0.27, 0.993, 140, 140, CRYSTAL STRUCTURE OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR
355, 3gjsC, 0.5843, 0.28, 0.993, 140, 140, CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES
356, 1rhjC, 0.5842, 0.30, 0.993, 140, 140, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PRYAZINONE INHIBITOR
357, 1pauA, 0.5842, 0.30, 0.993, 140, 140, CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE ALDEHYDE INHIBITOR AC-DEVD-CHO
358, 2y0bA, 0.5841, 0.30, 0.993, 140, 140, CASPASE-3 IN COMPLEX WITH AN INHIBITORY DARPIN-3.4_S76R
359, 2h5jC, 0.5841, 0.30, 0.993, 140, 140, CRYSTAL STRUSTURE OF CASPASE-3 WITH INHIBITOR AC-DMQD-CHO
360, 2xzdA, 0.5840, 0.32, 0.993, 140, 140, CASPASE-3 IN COMPLEX WITH AN INHIBITORY DARPIN-3.4
361, 2y0bC, 0.5837, 0.34, 0.993, 140, 140, CASPASE-3 IN COMPLEX WITH AN INHIBITORY DARPIN-3.4_S76R
362, 2xztA, 0.5835, 0.36, 0.993, 140, 140, CASPASE-3 IN COMPLEX WITH DARPIN-3.4_I78S
363, 1rhmA, 0.5834, 0.37, 0.993, 140, 140, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR
364, 2xztC, 0.5829, 0.40, 0.993, 141, 140, CASPASE-3 IN COMPLEX WITH DARPIN-3.4_I78S
365, 3gjtC, 0.5826, 0.43, 0.993, 140, 140, CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES
366, 1rhmC, 0.5825, 0.43, 0.993, 140, 140, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR
367, 1rhuA, 0.5823, 0.45, 0.993, 140, 140, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A 567 TRICYCLIC PEPTIDOMIMETIC INHIBITOR
368, 2h65A, 0.5817, 0.49, 0.993, 140, 140, CRYSTAL STRUSTURE OF CASPASE-3 WITH INHIBITOR AC-VDVAD-CHO
369, 3gjqC, 0.5816, 0.50, 0.993, 140, 140, CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES
370, 5ic6C, 0.5814, 0.50, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 DEVE PEPTIDE COMPLEX
371, 4zvtC, 0.5814, 0.50, 0.507, 140, 140, CASPASE-7 VARIANT 1 (V1) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230A/W232M/S234N SUBSTITUTIONS BOUND TO VEID INHIBITOR.
372, 1rhrA, 0.5814, 0.50, 0.993, 140, 140, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A CINNAMIC ACID METHYL ESTER INHIBITOR
373, 1rhqD, 0.5814, 0.50, 0.993, 140, 140, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A BROMOMETHOXYPHENYL INHIBITOR
374, 1rhqA, 0.5814, 0.50, 0.993, 140, 140, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A BROMOMETHOXYPHENYL INHIBITOR
375, 2qljA, 0.5811, 0.52, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-WEHD-CHO
376, 2ql9A, 0.5811, 0.52, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DQMD-CHO
377, 3ibcA, 0.5810, 0.52, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 INCOMPLEX WITH ACETYL-YVAD- CHO
378, 2ql5A, 0.5810, 0.52, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DMQD-CHO
379, 4zvoC, 0.5809, 0.53, 0.507, 140, 140, CASPASE-7 VARIANT 4 (V4) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232Y/S234V/Q276D SUBSTITUTIONS BOUND TO VEID INHIBITOR.
380, 2qljC, 0.5809, 0.53, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-WEHD-CHO
381, 5ic4C, 0.5808, 0.20, 0.993, 139, 139, CRYSTAL STRUCTURE OF CASPASE-3 DEVE PEPTIDE COMPLEX
382, 3edqA, 0.5808, 0.55, 0.993, 140, 140, CRYSTAL STRUCTURE OF CASPASE-3 WITH INHIBITOR AC-LDESD-CHO
383, 4zvuC, 0.5807, 0.54, 0.507, 140, 140, CASPASE-7 WILD-TYPE BOUND TO THE CASPASE-6 COGNATE TETRAPEPTIDE INHIBITOR AC-VEID-CHO
384, 4zvsC, 0.5807, 0.54, 0.507, 140, 140, CASPASE-7 VARIANT 1 (V1) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230A/W232M/S234N SUBSTITUTIONS BOUND TO DEVD INHIBITOR.
385, 3ibcC, 0.5807, 0.54, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 INCOMPLEX WITH ACETYL-YVAD- CHO
386, 2qlbA, 0.5806, 0.54, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-ESMD-CHO
387, 2ql7A, 0.5806, 0.54, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-IEPD-CHO
388, 5ic6A, 0.5805, 0.55, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 DEVE PEPTIDE COMPLEX
389, 5ic4E, 0.5805, 0.24, 0.993, 139, 139, CRYSTAL STRUCTURE OF CASPASE-3 DEVE PEPTIDE COMPLEX
390, 4zvqC, 0.5805, 0.55, 0.507, 140, 140, CASPASE-7 VARIANT 2 (V2) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232M/Q276C SUBSTITUTIONS BOUND TO VEID INHIBITOR.
391, 3ibfA, 0.5805, 0.55, 0.507, 140, 140, CRYSTAL STRUCTURE OF UNLIGANDED CASPASE-7
392, 2qlfC, 0.5805, 0.55, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DNLD-CHO
393, 5ic4G, 0.5804, 0.25, 0.993, 139, 139, CRYSTAL STRUCTURE OF CASPASE-3 DEVE PEPTIDE COMPLEX
394, 2ql9C, 0.5803, 0.56, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DQMD-CHO
395, 5k20C, 0.5802, 0.57, 0.507, 140, 140, CASPASE-7 S239E PHOSPHOMIMETIC
396, 4zvpC, 0.5802, 0.57, 0.507, 140, 140, CASPASE-7 VARIANT 2 (V2) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232M/Q276C SUBSTITUTIONS BOUND TO DEVD INHIBITOR.
397, 2qlbC, 0.5802, 0.57, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-ESMD-CHO
398, 2ql7C, 0.5802, 0.57, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-IEPD-CHO
399, 5k20A, 0.5800, 0.58, 0.507, 140, 140, CASPASE-7 S239E PHOSPHOMIMETIC
400, 5ic4A, 0.5799, 0.31, 0.993, 139, 139, CRYSTAL STRUCTURE OF CASPASE-3 DEVE PEPTIDE COMPLEX
401, 4lszC, 0.5799, 0.59, 0.507, 141, 140, CASPASE-7 IN COMPLEX WITH DARPIN D7.18
402, 2ql5C, 0.5797, 0.59, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DMQD-CHO
403, 4lszA, 0.5796, 0.61, 0.507, 140, 140, CASPASE-7 IN COMPLEX WITH DARPIN D7.18
404, 4zvqA, 0.5773, 0.50, 0.511, 139, 139, CASPASE-7 VARIANT 2 (V2) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232M/Q276C SUBSTITUTIONS BOUND TO VEID INHIBITOR.
405, 4zvpA, 0.5773, 0.49, 0.511, 139, 139, CASPASE-7 VARIANT 2 (V2) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232M/Q276C SUBSTITUTIONS BOUND TO DEVD INHIBITOR.
406, 4zvtA, 0.5771, 0.51, 0.511, 139, 139, CASPASE-7 VARIANT 1 (V1) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230A/W232M/S234N SUBSTITUTIONS BOUND TO VEID INHIBITOR.
407, 4zvoA, 0.5771, 0.51, 0.511, 139, 139, CASPASE-7 VARIANT 4 (V4) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232Y/S234V/Q276D SUBSTITUTIONS BOUND TO VEID INHIBITOR.
408, 4zvrA, 0.5769, 0.52, 0.511, 139, 139, CASPASE-7 VARIANT 4 (V4) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232Y/S234V/Q276D SUBSTITUTIONS BOUND TO DEVD INHIBITOR.
409, 4zvuA, 0.5768, 0.52, 0.511, 139, 139, CASPASE-7 WILD-TYPE BOUND TO THE CASPASE-6 COGNATE TETRAPEPTIDE INHIBITOR AC-VEID-CHO
410, 4zvsA, 0.5768, 0.53, 0.511, 139, 139, CASPASE-7 VARIANT 1 (V1) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230A/W232M/S234N SUBSTITUTIONS BOUND TO DEVD INHIBITOR.
411, 3edrA, 0.5768, 0.52, 0.511, 139, 139, THE CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-LDESD-CHO
412, 2qlfA, 0.5767, 0.53, 0.511, 139, 139, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DNLD-CHO
413, 3sipC, 0.5766, 1.35, 0.343, 152, 143, CRYSTAL STRUCTURE OF DRICE AND DIAP1-BIR1 COMPLEX
414, 4zvrC, 0.5765, 0.54, 0.511, 139, 139, CASPASE-7 VARIANT 4 (V4) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232Y/S234V/Q276D SUBSTITUTIONS BOUND TO DEVD INHIBITOR.
415, 3sipA, 0.5765, 1.35, 0.343, 149, 143, CRYSTAL STRUCTURE OF DRICE AND DIAP1-BIR1 COMPLEX
416, 1i51C, 0.5755, 0.60, 0.504, 139, 139, CRYSTAL STRUCTURE OF CASPASE-7 COMPLEXED WITH XIAP
417, 1i51A, 0.5754, 0.60, 0.504, 139, 139, CRYSTAL STRUCTURE OF CASPASE-7 COMPLEXED WITH XIAP
418, 3p4uA, 0.5724, 1.36, 0.397, 143, 141, CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 IN COMPLEX WITH AC-VEID-CHO INHIBITOR
419, 3p4uC, 0.5723, 1.37, 0.397, 143, 141, CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 IN COMPLEX WITH AC-VEID-CHO INHIBITOR
420, 1f9eC, 0.5723, 1.49, 0.413, 153, 143, CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO
421, 1f9eI, 0.5722, 1.50, 0.413, 153, 143, CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO
422, 1f9eG, 0.5721, 1.50, 0.413, 153, 143, CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO
423, 1f9eE, 0.5721, 1.49, 0.413, 153, 143, CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO
424, 1f9eA, 0.5720, 1.53, 0.413, 153, 143, CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO
425, 1qduK, 0.5717, 1.53, 0.413, 153, 143, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK
426, 1qduG, 0.5716, 1.53, 0.413, 153, 143, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK
427, 1qduC, 0.5716, 1.53, 0.413, 153, 143, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK
428, 1f9eK, 0.5714, 1.54, 0.413, 153, 143, CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO
429, 1qduI, 0.5706, 1.57, 0.413, 153, 143, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK
430, 1qduE, 0.5704, 1.58, 0.413, 153, 143, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK
431, 3kjnA, 0.5702, 1.45, 0.408, 152, 142, CASPASE 8 BOUND TO A COVALENT INHIBITOR
432, 1qduA, 0.5702, 1.59, 0.413, 153, 143, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK
433, 1pyoC, 0.5702, 1.58, 0.336, 161, 143, CRYSTAL STRUCTURE OF HUMAN CASPASE-2 IN COMPLEX WITH ACETYL-LEU-ASP- GLU-SER-ASP-CHO
434, 3r7nC, 0.5701, 1.59, 0.336, 160, 143, CASPASE-2 BOUND WITH TWO COPIES OF AC-DVAD-CHO
435, 3r7bC, 0.5697, 1.60, 0.336, 159, 143, CASPASE-2 BOUND TO ONE COPY OF AC-DVAD-CHO
436, 3r6gC, 0.5696, 1.60, 0.336, 160, 143, CRYSTAL STRUCTURE OF ACTIVE CASPASE-2 BOUND WITH AC-VDVAD-CHO
437, 3r6lC, 0.5695, 1.60, 0.336, 160, 143, CASPASE-2 T380A BOUND WITH AC-VDVAD-CHO
438, 3r7sC, 0.5694, 1.60, 0.336, 159, 143, CRYSTAL STRUCTURE OF APO CASPASE2
439, 3r5jC, 0.5694, 1.61, 0.336, 159, 143, CRYSTAL STRUCTURE OF ACTIVE CASPASE-2 BOUND WITH AC-ADVAD-CHO
440, 3rjmC, 0.5693, 1.61, 0.336, 160, 143, CASPASE2 IN COMPLEX WITH CHDI LIGAND 33C
441, 3r7sA, 0.5693, 1.58, 0.336, 159, 143, CRYSTAL STRUCTURE OF APO CASPASE2
442, 3kjqA, 0.5690, 1.48, 0.408, 152, 142, CASPASE 8 WITH COVALENT INHIBITOR
443, 1qtnA, 0.5686, 1.50, 0.408, 152, 142, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TETRAPEPTIDE INHIBITOR ACE-IETD-ALDEHYDE
444, 3rjmA, 0.5678, 1.64, 0.336, 159, 143, CASPASE2 IN COMPLEX WITH CHDI LIGAND 33C
445, 2c2zA, 0.5678, 1.25, 0.404, 149, 141, CRYSTAL STRUCTURE OF CASPASE-8 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITOR
446, 2p2cI, 0.5676, 1.86, 0.326, 157, 144, INHIBITION OF CASPASE-2 BY A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN)
447, 2p2cG, 0.5670, 1.88, 0.333, 160, 144, INHIBITION OF CASPASE-2 BY A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN)
448, 1pyoA, 0.5659, 1.60, 0.338, 159, 142, CRYSTAL STRUCTURE OF HUMAN CASPASE-2 IN COMPLEX WITH ACETYL-LEU-ASP- GLU-SER-ASP-CHO
449, 2p2cC, 0.5656, 1.68, 0.336, 161, 143, INHIBITION OF CASPASE-2 BY A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN)
450, 2y1lA, 0.5655, 1.47, 0.415, 150, 142, CASPASE-8 IN COMPLEX WITH DARPIN-8.4
451, 2p2cA, 0.5647, 1.72, 0.336, 162, 143, INHIBITION OF CASPASE-2 BY A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN)
452, 2p2cE, 0.5630, 1.98, 0.333, 160, 144, INHIBITION OF CASPASE-2 BY A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN)
453, 5obtB, 0.5613, 2.86, 0.096, 229, 157, FULLY ACTIVATED A. THALIANA LEGUMAIN ISOFORM GAMMA IN COMPLEX WITH AC- YVAD-CMK 
454, 3r6gA, 0.5613, 1.61, 0.340, 157, 141, CRYSTAL STRUCTURE OF ACTIVE CASPASE-2 BOUND WITH AC-VDVAD-CHO
455, 2p2cK, 0.5612, 1.60, 0.338, 158, 142, INHIBITION OF CASPASE-2 BY A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN)
456, 2y1lC, 0.5609, 1.33, 0.414, 148, 140, CASPASE-8 IN COMPLEX WITH DARPIN-8.4
457, 3r7bA, 0.5581, 1.58, 0.343, 156, 140, CASPASE-2 BOUND TO ONE COPY OF AC-DVAD-CHO
458, 5obtA, 0.5559, 2.82, 0.097, 227, 155, FULLY ACTIVATED A. THALIANA LEGUMAIN ISOFORM GAMMA IN COMPLEX WITH AC- YVAD-CMK 
459, 3r6lA, 0.5549, 1.57, 0.345, 155, 139, CASPASE-2 T380A BOUND WITH AC-VDVAD-CHO
460, 3r7nA, 0.5522, 1.54, 0.348, 154, 138, CASPASE-2 BOUND WITH TWO COPIES OF AC-DVAD-CHO
461, 3r5jA, 0.5522, 1.54, 0.348, 154, 138, CRYSTAL STRUCTURE OF ACTIVE CASPASE-2 BOUND WITH AC-ADVAD-CHO
462, 1rwmA, 0.5454, 2.13, 0.291, 173, 141, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-[2-(5- {[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-THIOPHEN-2-YL)- ACETYLAMINO]-PENTANOIC ACID
463, 1ibcA, 0.5452, 2.21, 0.291, 167, 141, CRYSTAL STRUCTURE OF INHIBITED INTERLEUKIN-1BETA CONVERTING ENZYME
464, 6f6rA, 0.5446, 2.09, 0.291, 180, 141, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 WITH N-{3-[1-((S)-2-HYDROXY-5- OXO-TETRAHYDRO-FURAN-3-YLCARBAMOYL)-ETHYL]-1-METHYL-2;4-DIOXO-1;2;3; 4-TETRAHYDRO-PYRIMIDIN-5-YL}-4-(QUINOXALIN-2-YLAMINO)-BENZAMIDE 
465, 1iceA, 0.5446, 2.19, 0.291, 167, 141, STRUCTURE AND MECHANISM OF INTERLEUKIN-1BETA CONVERTING ENZYME
466, 1rwwA, 0.5443, 2.21, 0.291, 175, 141, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-[(6-{[4- (QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-PYRIDINE-3-CARBONYL)- AMINO]-BUTYRIC ACID
467, 6bz9A, 0.5442, 2.01, 0.293, 171, 140, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH AC-FLTD-CMK 
468, 1rwnA, 0.5440, 2.03, 0.293, 173, 140, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-{2-ETHYL-6-[4- (QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-HEXANOYLAMINO}-4-OXO-BUTYRIC ACID
469, 1rwkA, 0.5440, 2.03, 0.293, 173, 140, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-(2-MERCAPTO- ACETYLAMINO)-4-OXO-PENTANOIC ACID
470, 1bmqA, 0.5440, 2.24, 0.291, 167, 141, CRYSTAL STRUCTURE OF THE COMPLEX OF INTERLEUKIN-1BETA CONVERTING ENZYME (ICE) WITH A PEPTIDE BASED INHIBITOR (3S )-N-METHANESULFONYL-3-({1-[N-(2-NAPHTOYL)-L-VALYL]-L- PROLYL }AMINO)-4-OXOBUTANAMIDE
471, 1rwxA, 0.5435, 2.05, 0.293, 178, 140, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-{6-[4- (QUINOXALIN-2-YLOXY)-BENZOYLAMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}- BUTYRIC ACID
472, 1rwpA, 0.5435, 2.07, 0.293, 173, 140, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-{6-[(8-HYDROXY- QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO- BUTYRIC ACID
473, 1rwvA, 0.5433, 2.08, 0.293, 173, 140, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 5-[5-(1- CARBOXYMETHYL-2-OXO-PROPYLCARBAMOYL)-5-PHENYL-PENTYLSULFAMOYL]-2- HYDROXY-BENZOIC ACID
474, 3d6hA, 0.5432, 2.14, 0.286, 166, 140, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 WITH A NATURALLY-OCCURRING ASN263->SER SUBSTITUTION IN COMPLEX WITH 3-[2-(2- BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO- PENTANOIC ACID (Z-VAD-FMK)
475, 1sc3A, 0.5432, 2.07, 0.286, 173, 140, CRYSTAL STRUCTURE OF THE HUMAN CASPASE-1 C285A MUTANT IN COMPLEX WITH MALONATE
476, 1rwoA, 0.5432, 2.08, 0.293, 173, 140, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-{6-[4- (QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}- PENTANOIC ACID
477, 3d6mA, 0.5431, 2.08, 0.293, 173, 140, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 WITH A NATURALLY-OCCURRING LYS319->ARG SUBSTITUTION IN COMPLEX WITH 3-[2-(2- BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO- PENTANOIC ACID (Z-VAD-FMK)
478, 2h48A, 0.5431, 2.07, 0.293, 173, 140, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (CYS362->ALA CYS364->ALA CYS397->ALA) IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL- BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)
479, 3d6fA, 0.5426, 2.08, 0.293, 173, 140, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 WITH A NATURALLY-OCCURRING ARG240->GLN SUBSTITUTION IN COMPLEX WITH 3-[2-(2- BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO- PENTANOIC ACID (Z-VAD-FMK)
480, 2hbyA, 0.5425, 1.88, 0.295, 170, 139, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (GLU390->ALA) IN COMPLEX WITH 3- [2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID (Z-VAD-FMK)
481, 3ns7A, 0.5422, 2.11, 0.293, 162, 140, SUCCINIC ACID AMIDES AS P2-P3 REPLACEMENTS FOR INHIBITORS OF INTERLEUKIN-1BETA CONVERTING ENZYME (ICE OR CASPASE 1)
482, 5mtkA, 0.5421, 1.86, 0.295, 166, 139, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 WITH (3S6S10AS)-N-((2S3S)-2- HYDROXY-5-OXOTETRAHYDROFURAN-3-YL)-6-(ISOQUINOLINE-1-CARBOXAMIDO)-5- OXODECAHYDROPYRROLO[12-A]AZOCINE-3-CARBOXAMIDE (PGE-3935199)
483, 5mmvA, 0.5421, 1.95, 0.295, 166, 139, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 WITH 2-((2-NAPHTHOYL)-L-VALYL)-4- HYDROXY-N-((3S)-2-HYDROXY-5-OXOTETRAHYDROFURAN-3-YL)-2- AZABICYCLO[2.2.2]OCTANE-3-CARBOXAMIDE (COMPOUND 1)
484, 1sc4A, 0.5421, 2.27, 0.277, 166, 141, CRYSTAL STRUCTURE OF THE HUMAN CASPASE-1 C285A MUTANT AFTER REMOVAL OF MALONATE
485, 2h4yA, 0.5419, 1.99, 0.288, 163, 139, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (ARG286->LYS) IN COMPLEX WITH 3- [2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID (Z-VAD-FMK)
486, 2hbzA, 0.5418, 1.99, 0.288, 163, 139, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (ARG286->ALA GLU390->ALA) IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)- PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)
487, 2h54A, 0.5418, 1.89, 0.295, 170, 139, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (THR388->ALA) IN COMPLEX WITH 3- [2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID (Z-VAD-FMK)
488, 2h51A, 0.5418, 1.99, 0.288, 167, 139, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (GLU390->ASP AND ARG286->LYS) IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)- PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)
489, 1sc1A, 0.5414, 2.06, 0.286, 167, 140, CRYSTAL STRUCTURE OF AN ACTIVE-SITE LIGAND-FREE FORM OF THE HUMAN CASPASE-1 C285A MUTANT
490, 2hbrA, 0.5390, 1.92, 0.290, 168, 138, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (ARG286->ALA) IN COMPLEX WITH 3- [2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID (Z-VAD-FMK)
491, 2hbqA, 0.5387, 1.93, 0.297, 168, 138, CRYSTAL STRUCTURE OF WILDTYPE HUMAN CASPASE-1 IN COMPLEX WITH 3-[2-(2- BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO- PENTANOIC ACID (Z-VAD-FMK)
492, 2h4wA, 0.5382, 1.96, 0.297, 168, 138, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (GLU390->ASP) IN COMPLEX WITH 3- [2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID (Z-VAD-FMK)
493, 3p45M, 0.5380, 1.26, 0.402, 133, 132, CRYSTAL STRUCTURE OF APO-CASPASE-6 AT PHYSIOLOGICAL PH
494, 3p45A, 0.5373, 1.27, 0.402, 133, 132, CRYSTAL STRUCTURE OF APO-CASPASE-6 AT PHYSIOLOGICAL PH
495, 3p45I, 0.5367, 1.31, 0.402, 133, 132, CRYSTAL STRUCTURE OF APO-CASPASE-6 AT PHYSIOLOGICAL PH
496, 3p45K, 0.5363, 1.29, 0.402, 133, 132, CRYSTAL STRUCTURE OF APO-CASPASE-6 AT PHYSIOLOGICAL PH
497, 3p45E, 0.5340, 1.26, 0.397, 132, 131, CRYSTAL STRUCTURE OF APO-CASPASE-6 AT PHYSIOLOGICAL PH
498, 3p45G, 0.5337, 1.26, 0.397, 131, 131, CRYSTAL STRUCTURE OF APO-CASPASE-6 AT PHYSIOLOGICAL PH
499, 2fqqA, 0.5332, 1.74, 0.294, 147, 136, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (CYS285->ALA CYS362->ALA CYS364->ALA CYS397->ALA) IN COMPLEX WITH 1-METHYL-3-TRIFLUOROMETHYL- 1H-THIENO[23-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE
500, 3p45C, 0.5331, 1.29, 0.397, 132, 131, CRYSTAL STRUCTURE OF APO-CASPASE-6 AT PHYSIOLOGICAL PH
501, 3p45O, 0.5328, 1.31, 0.397, 132, 131, CRYSTAL STRUCTURE OF APO-CASPASE-6 AT PHYSIOLOGICAL PH
